ECSP024406A - MULTIVALENT VACCINE COMPOSITION - Google Patents
MULTIVALENT VACCINE COMPOSITIONInfo
- Publication number
- ECSP024406A ECSP024406A EC2002004406A ECSP024406A ECSP024406A EC SP024406 A ECSP024406 A EC SP024406A EC 2002004406 A EC2002004406 A EC 2002004406A EC SP024406 A ECSP024406 A EC SP024406A EC SP024406 A ECSP024406 A EC SP024406A
- Authority
- EC
- Ecuador
- Prior art keywords
- hepatitis
- virus
- vaccine composition
- multivalent vaccine
- haemophilus influenzae
- Prior art date
Links
- 229940031348 multivalent vaccine Drugs 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 3
- 241000588832 Bordetella pertussis Species 0.000 abstract 2
- 241000193449 Clostridium tetani Species 0.000 abstract 2
- 241000186216 Corynebacterium Species 0.000 abstract 2
- 241000606768 Haemophilus influenzae Species 0.000 abstract 2
- 241000700721 Hepatitis B virus Species 0.000 abstract 2
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 241000709721 Hepatovirus A Species 0.000 abstract 1
- 229940047650 haemophilus influenzae Drugs 0.000 abstract 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
El invento se refiere a vacunas de combinación que pueden prevenir ante Bordetella pertussis, Clostridium tetani, Corynebacterium diphteriae, y opcionalmente, el virus de la hepatitis B y/o Haemophilus influenzae de tipo b. Sin embargo, la fabricación y el empleo de vacunas multivalentes más ambiciosas son todavía un desafío. La administración de dichas vacunas multivalentes puede prevenir o tratar la infección por Bordetella pertussis, Clostridium tetani, Corynebacterium diphteriae, virus de la hepatitis B, Haemophilus influenzae y N meningitidis y preferiblemente también el virus de la hepatitis A y/o el virus de la polio, en las que los componentes de la vacuna no interfieren significativamente con la actividad inmunológica de cualquiera de los componentes de la vacuna.The invention relates to combination vaccines that can prevent before Bordetella pertussis, Clostridium tetani, Corynebacterium diphteriae, and optionally, hepatitis B virus and / or Haemophilus influenzae type b. However, the manufacture and use of more ambitious multivalent vaccines are still a challenge. The administration of said multivalent vaccines can prevent or treat infection by Bordetella pertussis, Clostridium tetani, Corynebacterium diphteriae, hepatitis B virus, Haemophilus influenzae and N meningitidis and preferably also hepatitis A virus and / or poliovirus. , in which the vaccine components do not significantly interfere with the immunological activity of any of the vaccine components.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0015999.6A GB0015999D0 (en) | 2000-06-29 | 2000-06-29 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP024406A true ECSP024406A (en) | 2003-04-25 |
Family
ID=9894692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004406A ECSP024406A (en) | 2000-06-29 | 2002-12-27 | MULTIVALENT VACCINE COMPOSITION |
Country Status (3)
| Country | Link |
|---|---|
| EC (1) | ECSP024406A (en) |
| GB (1) | GB0015999D0 (en) |
| ZA (1) | ZA200300755B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102302776B (en) * | 2003-01-30 | 2014-06-18 | 诺华疫苗和诊断有限公司 | Injectable vaccines against multiple meningococcal serogroups |
-
2000
- 2000-06-29 GB GBGB0015999.6A patent/GB0015999D0/en not_active Ceased
-
2002
- 2002-12-27 EC EC2002004406A patent/ECSP024406A/en unknown
-
2003
- 2003-01-28 ZA ZA200300755A patent/ZA200300755B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0015999D0 (en) | 2000-08-23 |
| ZA200300755B (en) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2097102T3 (en) | Combination vaccine with reduced amounts of poliovirus antigen | |
| NO20015073L (en) | vaccinations | |
| DK0914153T3 (en) | Multivalent DTP polio vaccines | |
| DK1459766T3 (en) | Adjuvant Compositions to Boost Immune Responses to Polynucleotide-Based Vaccines | |
| DK0724431T3 (en) | Methods and compositions for microencapsulating adjuvants | |
| BR0208595A (en) | vaccine kit, multivalent immunogenic composition, use thereof, method of immunization of a human host against disease caused by bordetella pertussis, clostridium tetani, corynebacterium diphtheriae, hepatitis b virus, poliovirus and n. meningitidis, process for producing multivalent immunogenic composition, and method for immunizing a human host against disease caused by haemophilus influenzae and streptococcus pneumoniae | |
| MY149604A (en) | C.perfringens alpha toxoid vaccine | |
| ATE125568T1 (en) | RECOMBINANT DNA-DERIVED BORDETELLA TOXIN SUBUNIT ANALOGUE. | |
| LU91596I2 (en) | Combination of diphtheria toxoid, tetanus toxoid, pertussis antoxin, filamentous hemagglutinin, pertactin, inactivated poliovirus type 1, type 2 and type 3 and capsular polysaccharide of haemophilus influenzae type b (Infanrix - IPV / Hib) | |
| HUP9904287A1 (en) | Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids | |
| EA200700496A1 (en) | INACTIVATED POLYOMYELITE VACCINE, RECEIVED FROM STRAIN OF SEIBIN VIRUS OF POLIOMYELITIS | |
| PE20211648A1 (en) | COMPOSITION OF COMBINED VACCINE INCLUDING REDUCED DOSES OF INACTIVATED POLIO VIRUS AND METHOD OF PREPARING IT | |
| ATE521621T1 (en) | CPG SINGLE STRAND DESOXYNUCLEOTIDES FOR USE AS ADJUVANTS | |
| ECSP024406A (en) | MULTIVALENT VACCINE COMPOSITION | |
| BR112019003419A2 (en) | multivalent vaccine composition | |
| AR117191A1 (en) | IMMUNOGENIC COMPOSITIONS | |
| BRPI0411815A (en) | y-type neisseria meningitidis vaccines and their meningococcal combinations | |
| DK0792347T3 (en) | Methods for Preparation of Enhanced Antigenic Heliobacter sp. and vaccines comprising the same | |
| DK0603386T3 (en) | Parenteral immunization against rotavirus | |
| UA95810C2 (en) | Inactivated poliovirus vaccine | |
| RU2002130182A (en) | METHOD FOR VACCINAL PREVENTION OF POLIOMYELITIS IN THE EXTREME NORTH | |
| GB9611501D0 (en) | Vaccine compositions | |
| Andre | New developments in vaccinology | |
| RU2003101497A (en) | METHOD FOR PREVENTION OF DTP VACCINE IN THE FAR NORTH | |
| RU99110617A (en) | METHOD OF SEASONAL VACCINE PREVENTION OF POLIOMYELITIS IN THE EXTREME NORTH |